Athens Medical C.S.A. (IATR) - Total Assets
Based on the latest financial reports, Athens Medical C.S.A. (IATR) holds total assets worth €526.18 Million EUR (≈ $615.16 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See Athens Medical C.S.A. (IATR) net assets for net asset value and shareholders' equity analysis.
Athens Medical C.S.A. - Total Assets Trend (2014–2024)
This chart illustrates how Athens Medical C.S.A.'s total assets have evolved over time, based on quarterly financial data.
Athens Medical C.S.A. - Asset Composition Analysis
Current Asset Composition (December 2024)
Athens Medical C.S.A.'s total assets of €526.18 Million consist of 38.7% current assets and 61.3% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 3.5% |
| Accounts Receivable | €122.43 Million | 24.7% |
| Inventory | €7.21 Million | 1.5% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €6.21 Million | 1.3% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2014–2024)
This chart illustrates how Athens Medical C.S.A.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see Athens Medical C.S.A. (IATR) market capitalisation.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Athens Medical C.S.A.'s current assets represent 38.7% of total assets in 2024, an increase from 34.1% in 2014.
- Cash Position: Cash and equivalents constituted 3.5% of total assets in 2024, up from 1.3% in 2014.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2014.
- Asset Diversification: The largest asset category is accounts receivable at 24.7% of total assets.
Athens Medical C.S.A. Competitors by Total Assets
Key competitors of Athens Medical C.S.A. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Fresenius Medical Care AG & Co. KGaA
XETRA:FME
|
Germany | €31.47 Billion |
|
Ramsay Health Care Ltd
AU:RHC
|
Australia | AU$21.70 Billion |
|
Huaxia Eye Hospital Group Co. Ltd. A
SHE:301267
|
China | CN¥8.17 Billion |
|
Mitra Keluarga Karyasehat Tbk PT
JK:MIKA
|
Indonesia | Rp9.64 Trillion |
|
MLP Saglik Hizmetleri AS
IS:MPARK
|
Turkey | TL89.94 Billion |
|
VITA 34 AG
XETRA:V3V
|
Germany | €168.26 Million |
|
P3 Health Partners Inc
NASDAQ:PIII
|
USA | $683.56 Million |
|
Bumrungrad Hospital Public Company Limited
F:BZ7A
|
Germany | €36.46 Billion |
Athens Medical C.S.A. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.81 | 0.91 | 0.81 |
| Quick Ratio | 0.79 | 0.88 | 0.77 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-49.97 Million | €-20.59 Million | €-27.28 Million |
Athens Medical C.S.A. - Advanced Valuation Insights
This section examines the relationship between Athens Medical C.S.A.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.50 |
| Latest Market Cap to Assets Ratio | 0.33 |
| Asset Growth Rate (YoY) | 3.9% |
| Total Assets | €495.86 Million |
| Market Capitalization | $163.93 Million USD |
Valuation Analysis
Below Book Valuation: The market values Athens Medical C.S.A.'s assets below their book value (0.33x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Athens Medical C.S.A.'s assets grew by 3.9% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Athens Medical C.S.A. (2014–2024)
The table below shows the annual total assets of Athens Medical C.S.A. from 2014 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | €495.86 Million ≈ $579.71 Million |
+3.88% |
| 2023-12-31 | €477.34 Million ≈ $558.06 Million |
+14.17% |
| 2022-12-31 | €418.09 Million ≈ $488.79 Million |
-1.10% |
| 2021-12-31 | €422.76 Million ≈ $494.25 Million |
+1.01% |
| 2020-12-31 | €418.54 Million ≈ $489.32 Million |
+13.70% |
| 2019-12-31 | €368.11 Million ≈ $430.36 Million |
+2.41% |
| 2018-12-31 | €359.46 Million ≈ $420.25 Million |
-0.55% |
| 2017-12-31 | €361.46 Million ≈ $422.58 Million |
-1.95% |
| 2016-12-31 | €368.66 Million ≈ $431.00 Million |
-0.43% |
| 2015-12-31 | €370.24 Million ≈ $432.85 Million |
-2.76% |
| 2014-12-31 | €380.74 Million ≈ $445.12 Million |
-- |
About Athens Medical C.S.A.
Athens Medical C.S.A., together with its subsidiaries, offers healthcare services in Greece and internationally. The company offers diagnosis and treatment for prostate bladder, kidney, and testicular cancer, as well as interventional cardiology, interventional electrophysiology, and pediatric cardiology; cardiac surgery; robotic surgery, including general, gynecologic, and urology services; and … Read more